References
- Parkin D, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74–108.
- Bruix J, Hessheimer A, Forner A, Boix L, Vilana R, Llovet J. New aspects of diagnosis and therapy of hepatocellular carcinoma. Oncogene 2006;25:3848–56.
- Liang P, Wang Y. Microwave ablation of hepatocellular carcinoma. Oncology 2007;72:124–31.
- Wang Y, Liang P, Yu X, Cheng Z, Yu J, Dong J. Ultrasound-guided percutaneous microwave ablation of adrenal metastasis: preliminary results. Int J Hyperther 2009;25:455–61.
- Zerbini A, Pilli M, Laccabue D, Pelosi G, Molinari A, Negri E, et al. Radiofrequency thermal ablation for hepatocellular carcinoma stimulates autologous NK-cell response. Gastroenterology 2010;138:1931–42.
- Lu S, Wang Y, Lu Y. The effect of thermal ablation therapy on regulatory T cells in hepatocellular carcinoma. Chin J Postgrad Med 2012;35:23–5.
- Chen A, Zhong Q. Effects of microwave ablation on immune function of patients with hepatocellular carcinoma. Chin J Gerontol 2012;32:3025–6.
- Liu D, Lv M, Tan J, Wang Z, Zhou Z, Huang J. Effect of microwave ablation on immunocyte and cytokine production in hepatocellular carcinoma mice. Basic Clin Med 2007;27:749–52.
- Biragyn A, Longo D. Neoplastic Black Ops: cancer's subversive tactics in overcoming host defenses. Semin Cancer Biol 2012;22:50–9.
- Visser K, Eichten A, Coussens L. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006;6:24–37.
- Dunn G, Old L, Schreiber R. The three Es of cancer immunoediting. Annu Rev Immunol 2004;22:329–60.
- Vivier E, Ugolini S, Blaise D, Chabannon C, Brossay L. Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol 2012;12:239–52.
- DeNardo D, Andreu P, Coussens L. Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer Metastasis Rev 2010;29:309–16.
- Chen X, Wang J, Wang R, Su Q, Luan J, Huang H, et al. Th1-, Th2-, and Th17-associated cytokine expression in hypopharyngeal carcinoma and clinical significance. Eur Arch Otorhinolaryngol 2016;273:431–8.
- Harrington L, Hatton R, Mangan P, Turner H, Murphy T, Murphy K, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005;6:1123–32.
- Park H, Li Z, Yang X, Chang S, Nurieva R, Wang Y, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005;6:1133–41.
- Korn T, Bettelli E, Oukka M, Kuchroo V. IL-17 and Th17 Cells. Annu Rev Immunol 2009;27:485–517.
- Yang W, Jiang N, Huang N, Huang J, Zheng Q, Shen Q. Combined therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation for small hepatocellular carcinoma. World J Gastroenterol 2009;15:748–52.
- Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008;454:436–44.
- Heim M. Innate immunity and HCV. J Hepatol 2013;58:564–74.
- Dadmanesh M, Ghorban K, Hassanshahi G, Momeni M, Arababadi M. Current information concerning association of IL-12 and hepatitis B infection. Clin Lab 2014;60:185–91.
- Becker Y. Molecular immunological approaches to biotherapy of human cancers-A review, hypothesis and implications. Anticancer Res 2006;26:1113–34.
- Takeuchi A, Dejima T, Yamada H, Shibata K, Nakamura R, Eto M, et al. IL-17 production by γδ T cells is important for the antitumor effect of Mycobacterium bovis bacillus Calmette-Guérin treatment against bladder cancer. Eur J Immunol 2011;41:246–51.
- Wilke C, Kryczek I, Wei S, Zhao E, Wu K, Wang G, et al. Th17 cells in cancer: help or hindrance?. Carcinogenesis 2011;32:643–9.
- Wang P, Wu C, Lv L, Zhang F. Expression and clinical significance of IL-17 in primary hepatocellular carcinoma tissues. Chin J Cancer Biother 2011;18:216–9.
- Liu J, Zhou G, Lu W. Plasma interleukin 17 in the diagnosis of hepatocellular carcinoma: a retrospective study of 39 cases. J Cancer Res Ther 2014;10:304–6.
- Liao R, Sun J, Wu H, Yi Y, Wang J, He H, et al. High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma. J Exp Clin Cancer Res 2013;32:3–57.